Idiopathic pneumonia after bone marrow transplantation: Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment
- 1 September 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (9) , 1800-1806
- https://doi.org/10.1097/00003246-199909000-00016
Abstract
To determine whether idiopathic pneumonia syndrome (IPS), a form of noninfectious lung injury that follows bone marrow transplantation, is associated with cytokine activation and increased susceptibility to lipopolysaccharide (LPS). Case series. Tertiary referral center for marrow transplantation. Recipients with biopsy-confirmed IPS; normal volunteers and marrow transplant recipients without IPS were analyzed as controls. Levels of lymphocyte and macrophage-derived cytokines as well as components of the LPS, LPS-binding protein (LBP), and CD14 system in bronchoalveolar lavage (BAL) fluid were determined. We found evidence of increased vascular permeability (BAL protein) and inflammatory cytokine activation (interleukin-1, interleukin-2, interleukin-6, and tumor necrosis factor-α) in patients with IPS. Patients without IPS had BAL fluid cytokine and protein levels that were similar to levels in BAL fluid from normal volunteers. Moreover, components of the LPS amplification system (LBP and soluble CD14) were increased in patients with IPS but not in patients without IPS. These results provide direct evidence for proinflammatory cytokine activation in IPS and suggest that these patients might be at increased risk for LPS-mediated injury through the LBP amplification pathway.Keywords
This publication has 29 references indexed in Scilit:
- Biological markers of acute lung injury: prognostic and pathogenetic significance.American Journal of Respiratory and Critical Care Medicine, 1997
- Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1996
- Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis SyndromeAnnals of Internal Medicine, 1993
- Expression of Tumor Necrosis Factor-α Gene in Alveolar Macrophages from Patients with the Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1993
- Idiopathic Pneumonia Syndrome after Bone Marrow TransplantationAmerican Review of Respiratory Disease, 1993
- Tumor Necrosis Factor Levels in Serum and Bronchoalveolar Lavage Fluid of Patients with the Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1991
- Cytokines of the LungAmerican Review of Respiratory Disease, 1990
- Compartmentalization of Intraalveolar and Systemic Lipopolysaccharide-Induced Tumor Necrosis Factor and the Pulmonary Inflammatory ResponseThe Journal of Infectious Diseases, 1989
- A significant part of macrophage-derived growth factor consists of at least two forms of PDGFCell, 1985
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985